Baidu
map

ESMO欢迎2017年世界卫生组织抗癌决议获得通过

2017-06-07 佚名 不详

瑞士卢加诺2017年6月2日电 /美通社/ -- 领先的欧洲专业内科肿瘤学组织ESMO(欧洲肿瘤内科学会)欢迎关于采用综合方法预防和控制癌症的决议在第70届世界卫生大会(WHA)上获得通过,5月22日至31日,该大会在瑞士日内瓦举行。

ESMO主席福尔图纳托-恰尔迪耶洛(Fortunato Ciardiello)表示:“ESMO欢迎该世界卫生组织(WHO)决议获得通过,这项决议旨在确保让癌症病人获得安全、有效和实惠的护理。癌症护理的可持续性是ESMO 2020愿景(ESMO 2020 Vision)的三大支柱之一。作为治疗癌症病人的肿瘤内科医师,我们坚定地倡导公平地获得高品质治疗。我们支持这项里程碑式世界卫生组织决议所涉及的相关各方,这明确表明了ESMO对全世界的承诺,而在这个世界中,癌症病人将会由高度专业化的专业人士进行照顾。”

恰尔迪耶洛补充说:“上次世界卫生组织抗癌决议还要追溯到2005年(网址:http://www.who.int/ipcs/publications/wha/cancer_resolution.pdf?ua=1 )。多年来,ESMO一直与世界卫生组织进行合作,以便改进癌症护理。至关重要的是,如今新的癌症病例持续增加,每年全球都能诊断出超过1400万新发癌症病例(网址:http://www.who.int/mediacentre/factsheets/fs297/en/ )。因此预防癌症不仅需要全球共同努力,还要确保无论那些受到癌症影响的人住在哪里、经济条件如何,他们都能获得最佳治疗和护理。”

2017年世界卫生组织抗癌决议呼吁制定全国的癌症控制计划,进行高品质的癌症注册登记,增加对癌症的研究,使用临床实践指南,及时获得药物、医疗设备和姑息治疗,以及培养受过良好训练的肿瘤问题相关人才。恰尔迪耶洛最后表示:“ESMO在以上这些领域都非常活跃,并且致力于为癌症专业人士提供高品质信息、资源和最佳教育。”

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1665308, encodeId=b3f616653087d, content=<a href='/topic/show?id=ea3020e82b6' target=_blank style='color:#2F92EE;'>#世界卫生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20782, encryptionId=ea3020e82b6, topicName=世界卫生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=416625942678, createdName=12498e87m47暂无昵称, createdTime=Wed Nov 22 00:16:00 CST 2017, time=2017-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2024791, encodeId=59822024e91dd, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16459, encryptionId=c27516459de, topicName=SMO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6779163, createdName=liuhuangbo, createdTime=Mon Oct 16 06:16:00 CST 2017, time=2017-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280938, encodeId=8081128093801, content=<a href='/topic/show?id=50d6e0215a' target=_blank style='color:#2F92EE;'>#ESMO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7021, encryptionId=50d6e0215a, topicName=ESMO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Fri Jun 09 07:16:00 CST 2017, time=2017-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1379345, encodeId=ff0a13e9345d4, content=<a href='/topic/show?id=88a720e859b' target=_blank style='color:#2F92EE;'>#世界卫生组织#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20785, encryptionId=88a720e859b, topicName=世界卫生组织)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c60d447, createdName=zhenjiu123, createdTime=Fri Jun 09 07:16:00 CST 2017, time=2017-06-09, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1665308, encodeId=b3f616653087d, content=<a href='/topic/show?id=ea3020e82b6' target=_blank style='color:#2F92EE;'>#世界卫生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20782, encryptionId=ea3020e82b6, topicName=世界卫生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=416625942678, createdName=12498e87m47暂无昵称, createdTime=Wed Nov 22 00:16:00 CST 2017, time=2017-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2024791, encodeId=59822024e91dd, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16459, encryptionId=c27516459de, topicName=SMO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6779163, createdName=liuhuangbo, createdTime=Mon Oct 16 06:16:00 CST 2017, time=2017-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280938, encodeId=8081128093801, content=<a href='/topic/show?id=50d6e0215a' target=_blank style='color:#2F92EE;'>#ESMO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7021, encryptionId=50d6e0215a, topicName=ESMO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Fri Jun 09 07:16:00 CST 2017, time=2017-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1379345, encodeId=ff0a13e9345d4, content=<a href='/topic/show?id=88a720e859b' target=_blank style='color:#2F92EE;'>#世界卫生组织#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20785, encryptionId=88a720e859b, topicName=世界卫生组织)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c60d447, createdName=zhenjiu123, createdTime=Fri Jun 09 07:16:00 CST 2017, time=2017-06-09, status=1, ipAttribution=)]
    2017-10-16 liuhuangbo
  3. [GetPortalCommentsPageByObjectIdResponse(id=1665308, encodeId=b3f616653087d, content=<a href='/topic/show?id=ea3020e82b6' target=_blank style='color:#2F92EE;'>#世界卫生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20782, encryptionId=ea3020e82b6, topicName=世界卫生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=416625942678, createdName=12498e87m47暂无昵称, createdTime=Wed Nov 22 00:16:00 CST 2017, time=2017-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2024791, encodeId=59822024e91dd, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16459, encryptionId=c27516459de, topicName=SMO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6779163, createdName=liuhuangbo, createdTime=Mon Oct 16 06:16:00 CST 2017, time=2017-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280938, encodeId=8081128093801, content=<a href='/topic/show?id=50d6e0215a' target=_blank style='color:#2F92EE;'>#ESMO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7021, encryptionId=50d6e0215a, topicName=ESMO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Fri Jun 09 07:16:00 CST 2017, time=2017-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1379345, encodeId=ff0a13e9345d4, content=<a href='/topic/show?id=88a720e859b' target=_blank style='color:#2F92EE;'>#世界卫生组织#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20785, encryptionId=88a720e859b, topicName=世界卫生组织)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c60d447, createdName=zhenjiu123, createdTime=Fri Jun 09 07:16:00 CST 2017, time=2017-06-09, status=1, ipAttribution=)]
    2017-06-09 hb2008ye
  4. [GetPortalCommentsPageByObjectIdResponse(id=1665308, encodeId=b3f616653087d, content=<a href='/topic/show?id=ea3020e82b6' target=_blank style='color:#2F92EE;'>#世界卫生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20782, encryptionId=ea3020e82b6, topicName=世界卫生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=416625942678, createdName=12498e87m47暂无昵称, createdTime=Wed Nov 22 00:16:00 CST 2017, time=2017-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2024791, encodeId=59822024e91dd, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16459, encryptionId=c27516459de, topicName=SMO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6779163, createdName=liuhuangbo, createdTime=Mon Oct 16 06:16:00 CST 2017, time=2017-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280938, encodeId=8081128093801, content=<a href='/topic/show?id=50d6e0215a' target=_blank style='color:#2F92EE;'>#ESMO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7021, encryptionId=50d6e0215a, topicName=ESMO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Fri Jun 09 07:16:00 CST 2017, time=2017-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1379345, encodeId=ff0a13e9345d4, content=<a href='/topic/show?id=88a720e859b' target=_blank style='color:#2F92EE;'>#世界卫生组织#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20785, encryptionId=88a720e859b, topicName=世界卫生组织)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c60d447, createdName=zhenjiu123, createdTime=Fri Jun 09 07:16:00 CST 2017, time=2017-06-09, status=1, ipAttribution=)]

相关资讯

房颤日里话房颤,专家建议积极预防、尽早治疗

心血管疾病在我国中老年人群中非常普遍。常见心血疾病有高血压、冠心病,心律失常等。心房颤动是最常见的心律失常疾病之一,简称“房颤”,主要表现为心房正常收缩功能丧失,心跳不规则。 /* Style Definitions */ span.prnews_span { font-size:8pt

OrbusNeich推出通过美国食品和药物管理局审批的冠脉扩张导管

专注提供可改变生活的血管解决方案的全球性公司OrbusNeich宣布推出不久前已通过美国食品和药物管理局(FDA) 510k审批的世界知名Sapphire PTCA(经皮冠状动脉腔内成形术)球囊扩张导管Sapphire™ II PRO和Sapphire™ NC Plus。

阿斯利康探索跨国药企与中国**科研机构合作的创新模式

5月26日,由北京大学鄂维南院士发起的北京大数据研究院与跨国制药企业阿斯利康公司在古朴雅静的北京大学静园成功签署了共建健康医疗大数据实验室合作协议。此项合作将依托北京大学健康医疗大数据研究中心的科研平台和科研团队,通过医疗大数据及大数据分析,为患者、医生、政府提供科学证据,并在健康医疗大数据领域探索高校与企业双方合作的创新模式。

Baidu
map
Baidu
map
Baidu
map